Not available
Quote | Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
Last: | $0.20 |
---|---|
Change Percent: | 11.65% |
Open: | $0.22 |
Close: | $0.20 |
High: | $0.22 |
Low: | $0.1827 |
Volume: | 877,543 |
Last Trade Date Time: | 07/06/2023 03:00:00 am |
News | Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
2023-07-06 04:15:37 ET Nymox Pharmaceutical ( NASDAQ: NYMX ) informed shareholders on Wednesday that it has received a delisting determination letter from Nasdaq on failing to regain with the minimum bid price requirement. The deadline to regain ...
IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq,...
Message Board Posts | Nymox Pharmaceutical Corporation (NASDAQ:NYMX)
Subject | By | Source | When |
---|---|---|---|
A one time injectable treatment for an enlarged | Spicknspan | investorshub | 01/30/2023 11:51:34 PM |
znewcar1: $NYMX 48% v1,4M c.7372 f90,5M H.7427 ML.2722 | znewcar1 | investorshangout | 12/08/2022 9:24:32 PM |
whytestocks: $NYMX News Article - Best Penny Stocks To Buy? 7 Under $1 To Watch Now | whytestocks | investorshangout | 12/06/2022 7:35:46 PM |
whytestocks: $NYMX News Article - Best Penny Stocks To Buy? 4 Under $1 To Watch Now | whytestocks | investorshangout | 12/05/2022 4:35:46 PM |
whytestocks: $NYMX News Article - NYMOX Announces New Marketing Submission for NYMOZARFEX(TM) for BP | whytestocks | investorshangout | 12/05/2022 3:10:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Nymox Pharmaceutical Corporation Company Name:
NYMX Stock Symbol:
NASDAQ Market:
Nymox Pharmaceutical Corporation Website:
IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq,...
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a mid-2nd quarter update on ongoing activities. The Company reported last month that it expects to submit an additional new submission for marketing...
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a current update on the Company's ongoing projects. The Company recently submitted its application for Marketing Authorization Application to the ...